Phase 4 PTSD Trial, Recruiting NCT06903819 Sponsor: Texas Tech University Health Sciences Center Condition: PTSD
Back to Ptsd

Phase 4 PTSD Trial, Recruiting

NCT06903819
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 18 and 65
  • People who are having urgent surgery to repair a bone or muscle injury
  • People whose injuries are considered serious, based on a standardized injury scoring system called the Injury Severity Score being greater than 15 (confirm with trial site)
  • People who are able to give their own consent to participate, or who have a legally authorized person who can give consent on their behalf

Who may not be able to join:

  • People who are younger than 18 or older than 65
  • People for whom a medication called ketamine is being used for sedation before or after surgery
  • People who have a known allergy or medical reason why ketamine would not be safe for them
  • People who have previously tried ketamine as a treatment for depression or PTSD and it did not work
  • People who have a severe psychiatric condition or symptoms of psychosis
  • People who have a history of dementia or glaucoma
  • People who are currently participating in a specific type of therapy for trauma or PTSD that was started within the last 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Principal Investigator: Max Evan Davis, MD, Texas Tech University Health Sciences Center Department of Orthopaedic Surgery,

Phone: 8067436846

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Texas Tech University Health Sciences Center
Registry
ClinicalTrials.gov
Start date
6 November 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Pain Intensity (VAS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov